Spotlight On Bladder Cancer
Bladder cancer is one of the most common cancers of the urinary tract, and ongoing advances in research are transforming how it is detected, treated, and managed. Here to help you stay up to date on all of the latest developments is our Spotlight On Bladder Cancer series, where you’ll find expert insights and clinical updates focused on improving outcomes across the care continuum.
1-12 of 12
Moving Toward Biomarker-Driven Care in Bladder Cancer
Project Oncology®Moving Toward Biomarker-Driven Care in Bladder Cancer
Benjamin Garmezy, MD
Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Project Oncology®Optimizing Patient Selection for Perioperative Therapy in Bladder Cancer
Benjamin Garmezy, MD
What's Next for Urothelial Cancer Treatment?
Project Oncology®What's Next for Urothelial Cancer Treatment?
Benjamin Garmezy, MD
Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Project Oncology®Monitoring Toxicities During Advanced Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Project Oncology®What’s Behind the Toxicity? Key Clues in Urothelial Carcinoma
Petros Grivas, MD, PhD
Supporting Patients Throughout Urothelial Carcinoma Treatment
Project Oncology®Supporting Patients Throughout Urothelial Carcinoma Treatment
Petros Grivas, MD, PhD
- advertisement
Current Approaches to Advanced Urothelial Carcinoma
Project Oncology®Current Approaches to Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Project Oncology®First-Line Treatment Considerations in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Project Oncology®Advanced Urothelial Carcinoma: Optimizing Second-Line Care
Guru P. Sonpavde, MD
The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Project Oncology®The Art of Treatment Sequencing in Advanced Urothelial Carcinoma
Guru P. Sonpavde, MD
Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Project Oncology®Urine RNA Panel Supports Less Invasive Bladder Cancer Surveillance
Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
Project Oncology®Can AI Imaging Improve Risk Stratification in Upper Tract Urothelial Carcinoma?
- advertisement